Answer
No pharmaceutical incompatibilities are specified for Atrovent UDVs (ipratropium bromide) nebuliser solution; section 6.2 states “Not applicable.”
Sources for this answer
- Atrovent 250 UDVs, 1 ml / Atrovent UDVs, 2 mlBoehringer Ingelheim Limited · emc · SmPC §6.2 Incompatibilities · Version 19Document updated
Sources checked